- $INJ has risen 18.42% to $7.82, showing continued bullish momentum.
- Resistance for $INJ lies near $8, with support around $6.75.
- Analysts see $12 as a key target for $INJ, reflecting a 140% potential gain.
Injective Protocol ($INJ) has shown impressive bullish momentum, with the price rising 18.42% in the last 24 hours to reach $7.82. The cryptocurrency is benefiting from increased market activity and is currently testing key resistance levels.
As of the latest data, the price has surged from a low near $6.75, indicating a steady upward trend. The recent upward movement has sparked speculation that $INJ could reach new highs in the coming weeks.
Resistance and Support Levels for $INJ
At the current price of $7.82, $INJ is facing resistance at the $8 mark. This level has proven to be a point of hesitation for the cryptocurrency, as seen in recent price action.
However, if the price continues its upward trajectory, it could breach this level and head towards higher targets.
Support for $INJ is currently located around $6.75, with traders looking for this level to hold. A further decline below this support could signal a reversal or consolidation. However, the ongoing bullish trend suggests that investors are optimistic about $INJ’s prospects.
Analysts Expect Price Target of $12 for $INJ
Based on recent market activity and technical analysis, experts are predicting that $INJ could continue its upward movement, with a potential price target of $12.46. This price would represent an increase of more than 40% from its current value.
A breakout above $8.00 could trigger further price action, with analysts forecasting continued bullish momentum through the end of 2025.
The market’s positive outlook is supported by strong buying pressure, with investors showing confidence in the token’s performance. Should $INJ reach its projected price target, it could potentially signal a broader market recovery, especially in the context of ongoing trends in Bitcoin and other major cryptocurrencies.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. CoinCryptoNewz is not responsible for any losses incurred. Readers should do their own research before making financial decisions.
